ERNA · Ernexa Therapeutics Inc. · Investor Relations
$2.11
-0.13 (-5.80%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 6, 2026
The latest filing states the doubt was alleviated.
“As of June 30, 2026, the Company had approximately $5.0 million in cash, which is less than that needed to effect its current operating plan and forecasted cash requirements for the next twelve months. However, management expects that its ability to access capital under its ATM will cover shortfalls in its cash resources over the next twelve months from the issuance date of these financial statements.”View the 10-Q filed Aug 6, 2026
Market Cap
$3.44M
Shares
1.63M
Volume · Oct 21
8513
Avg daily vol (3M)
54.2K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
No Investor Relations Content
No press releases or events have been collected for this stock yet.